Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Keertan Reddy

Psychiatry Greensboro, NC Medical Doctor

NPI 1114411105 CMS profile 4640938

603 Dolley Madison Rd Ste 100, Greensboro, NC 27410

Open in the dashboard

General payments

$1,917

70 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Keertan Reddy of Greensboro, NC is reported in the CMS Open Payments database as having received $1,917 across 70 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 79th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,458 61
2024 General $193 5
2023 General $99 1
2022 General $166 3

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Keertan Reddy
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Keertan Reddy were reported at $1,458. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Keertan Reddy Psychiatry median Middle half National median
2019 $0 $184 $59–$605 $163
2020 $0 $119 $36–$372 $114
2021 $0 $143 $43–$576 $132
2022 $166 $153 $50–$590 $149
2023 $99 $170 $56–$651 $160
2024 $193 $179 $57–$673 $164
2025 $1,458 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. AbbVie, Inc. $366 11 payments
  2. Neurocrine Biosciences, Inc. $361 13 payments
  3. Alkermes, Inc. $242 8 payments
  4. Otsuka America Pharmaceutical, Inc. $172 9 payments
  5. Vanda Pharmaceuticals Inc. $167 3 payments
  6. Janssen Scientific Affairs, LLC $128 1 payment
  7. E.R. Squibb & Sons, L.L.C. $102 4 payments
  8. Janssen Pharmaceuticals, Inc $92 5 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $73 5 payments
  10. ITI, Inc. $49 2 payments
  11. Other $164 9 payments

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $1,890 69 payments
  2. Debt forgiveness $27 1 payment
Products named General payments · program years 2022–2025
  1. INGREZZA $361 13 payments
  2. VRAYLAR Neuroscience $243 10 payments
  3. LYBALVI Cns $226 7 payments
  4. FANAPT $167 3 payments
  5. INVEGA SUSTENNA $128 1 payment
  6. VRAYLAR Neuroscience $123 1 payment
  7. REXULTI $120 5 payments
  8. LYBALVI Cns $114 2 payments
  9. LYBALVI Cns $114 2 payments
  10. LYBALVI Cns $114 2 payments
  11. Other $1,045 54 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 26 drugs

Part D claims

768

Median for Psychiatry: 574

Drug cost

$22,140

Median for Psychiatry: $27,624

Branded share of claims

7.8%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Vraylar Cariprazine Hcl Brand 11 $16,158
Aripiprazole Generic 53 $891
Olanzapine Generic 54 $586
Mirtazapine Generic 55 $486
Sertraline Hcl Generic 74 $464
Duloxetine Hcl Generic 40 $401
Quetiapine Fumarate Generic 59 $398
Divalproex Sodium Generic 23 $288
Bupropion Xl Bupropion Hcl Brand 20 $270
Prazosin Hcl Generic 16 $248

The 10 drugs with the highest cost, of 26 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 15 billing codes

Paid by Medicare

$78,454

Medicare's payments for the services billed

Medicare patients

170

Average age 61

Services billed

1,166

85 women, 85 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 75%
High blood pressure 69%
Arthritis 34%
Diabetes 31%
Ischemic heart disease 21%
Chronic kidney disease 19%
COPD 19%
Heart failure 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
FANAPT
  • Vanda Pharmaceuticals Inc. $136
$136 — —
TRINTELLIX
  • Takeda Pharmaceuticals U.S.A., Inc. $16
$16 — —
JORNAY PM
  • Ironshore Pharmaceuticals Inc. $16
$16 — —
LYBALVI
  • Alkermes, Inc. $15
$15 — —
HETLIOZ
  • Vanda Pharmaceuticals Inc. $11
$11 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

70 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in North Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record